Institutional Ownership
Citius Oncology Inc
CUSIP 17331Y109COMCTORQ1 2026
13D / 13G Filings
8
Schedule 13D/13G on record
Beneficial Filers
4
Distinct reporting persons
Largest Stake
92.6%
Max % of class reported
Institutional Holders
12
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
8 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | Armistice Capital, LLC | 13G/A | 10.0% | 8.08M | SEC |
| 2 | Dec 17, 2025 | Citius Pharmaceuticals, Inc. | 13D/A | 77.9% | — | SEC |
| 3 | Nov 14, 2025 | Armistice Capital, LLC | 13G | 9.8% | 7.68M | SEC |
| 4 | Sep 12, 2025 | Citius Pharmaceuticals, Inc. | 13D/A | 79.1% | — | SEC |
| 5 | Jul 25, 2025 | Citius Pharmaceuticals, Inc. | 13D/A | 84.3% | — | SEC |
| 6 | Nov 6, 2024 | Hudson Bay Capital Management LP | 13G/A | — | — | SEC |
| 7 | Aug 16, 2024 | Citius Pharmaceuticals, Inc. | 13D | 92.6% | 66.05M | SEC |
| 8 | Aug 15, 2024 | 10xyz Holdings LP | 13D/A | 2.8% | 1.98M | SEC |
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Armistice Capital, LLC | 9.19M | $5.70M |
| 2 | Bank Of America Corp /De/ | 3.84M | $2.37M |
| 3 | Geode Capital Management, LLC | 264.7K | $164.1K |
| 4 | Ifp Advisors, Inc | 107.4K | $66.6K |
| 5 | Blackrock, Inc. | 47.5K | $29.4K |
| 6 | Northern Trust Corp | 45.7K | $28.4K |
| 7 | State Street Corp | 42.9K | $26.6K |
| 8 | Ubs Group AG | 36.8K | $22.8K |
| 9 | Arkadios Wealth Advisors | 11.7K | $7.2K |
| 10 | Osaic Holdings, Inc. | 10.1K | $6.3K |